Author

Lei Wang

Observed name: Wang, Lei

Institution: Kunming Medical University

Observed institutions: Kunming Medical University, Peking University Cancer Hospital, Nanjing Drum Tower Hospital, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Nanjing University

ORCID: 0000-0001-9528-4437

Observed ORCID: 0000-0001-9528-4437

OpenAlex ID: A5013189262

Regorafenib with or without a programmed cell death protein 1 antibody as third‐line treatment for microsatellite stable metastatic colorectal cancer

2022 · Wen‐Zhuo He, Lei Wang, et al. · Cancer Medicine · 13

Targeting MEK/COX-2 axis improve immunotherapy efficacy in dMMR colorectal cancer with PIK3CA overexpression

2024 · Kunwei Peng, Yongxiang Liu, et al. · Cellular Oncology · 8

Distribution of regional lymph nodes metastasis in 870 cases of nasopharyngeal carcinoma and the suggestions for individualized elective prophylactic neck irradiation with intensity‐modulated radiotherapy

2023 · Lei Wang, Zheng Wu, et al. · Cancer Medicine · 8

Clinical outcomes of non‐nasopharyngeal lymphoepithelial carcinoma treated with a combined modality approach: A single‐institution study

2022 · Zichen Qiu, Feifei Lin, et al. · Cancer Medicine · 2

The role of YTHDF1 in the diagnosis and prognosis of lung adenocarcinoma and its inhibitor LY-411575 in the targeted intervention of lung adenocarcinoma growth

2025 · Lei Wang, Chaobo Li, et al. · Translational Cancer Research · 1

An AI-Powered tissue-agnostic cellular morphometrics biomarker for risk assessment in patients with pan-gastrointestinal precancerous lesions and cancers

2024 · Pin Wang, Chengfei Jiang, et al. · medRxiv

Works count: 8

Citation count: 32

H-index: 3

I10-index: 1